Medical Cannabis Use Rises with Age Among Cannabis Users, but Stays Constant Across the Full Adult Population
Medical cannabis use frequency epidemiology reveals that medical users consume cannabis more frequently than recreational-only users across all adult age groups. This pattern highlights the importance of understanding use frequency in clinical settings.…
Cannabis Use Among Individuals Treated with Medication for Opioid Use Disorder: Correlates, Patterns, and Motivations for Use
Cannabis use among individuals on MOUD is common and linked to various clinical factors. This study examines patterns and motivations for cannabis use in this population. Understanding these factors can inform clinical practice and patient care.
Endocannabinoid System Trauma Treatment and PTSD Research
Endocannabinoid system clinical research PTSD treatment reveals cannabis use does not impair trauma-focused therapy outcomes. Trauma-focused therapy remains effective for PTSD with substance use disorders. This research supports access to trauma-focused…
Impact of Combined Cannabinoids and Cocaine on Trauma Outcomes
This study investigates combined cannabinoids cocaine trauma outcomes in trauma patients. It analyzes mortality and clinical endpoints using a large trauma registry. Understanding these outcomes aids trauma care planning and substance use counseling.
Endocannabinoid System Research and Clinical Psychosis Care
Clinical psychosis care benefits from understanding the endocannabinoid system's role in first-episode psychosis. Research highlights predictors of legal involvement during early psychosis. This knowledge aids targeted interventions to improve patient…
Medical Cannabis Cuts Prescription Drug Use by 85%, German Patient Survey Finds
A German patient survey highlights prescription drug reduction medical cannabis effects, reporting an 85% decrease in prescription use. This finding has important implications for polypharmacy management and healthcare costs. However, the survey's…
A Major International Cannabis Study Is Being Planned—Here Is What Researchers Intend to Find Out
The blowing minds cannabis study protocol aims to untangle cannabis effects on mental health using innovative data-driven methods. This international study will track users across cultures and contexts. It represents a major step toward understanding…
Cannabis Europa Returns to London with Patient Issues on the Agenda
Cannabis patient advocacy initiatives are gaining prominence at Cannabis Europa in London. These initiatives emphasize patient-centered approaches to cannabis medicine development. They aim to improve clinical access and address real-world challenges in…
Ireland Moves Forward With Review of Medical Cannabis Programme
Ireland medical cannabis programme review marks a key step in evaluating clinical outcomes and patient access. This review will provide valuable data on regulatory effectiveness. It is a critical development for evidence-based cannabis medicine in Europe.
First Year of Dutch Cannabis Pilot Project a Success | StratCann
The Dutch cannabis pilot project success marks a significant milestone in regulated cannabis access. This first-year evaluation provides valuable insights into medical cannabis programs. The pilot's outcomes could influence future healthcare policies.